| Literature DB >> 29330272 |
Soraya Benguerfi1, Fanny Thepault1, Hervé Lena1,2, Charles Ricordel1,2.
Abstract
Splenic rupture is an infrequent and underdiagnosed side effect of granylocyte colony-stimulating factor (G-CSF). We report the case of a 54-year-old woman with brain and bone metastasis in a lung adenocarcinoma who was admitted for faintness 28 days after a G-CSF injection. Abdominal CT scan confirmed the diagnosis of splenic rupture. A conservative treatment was chosen using a peritoneal cleansing during laparoscopic surgery. Clinicians should be aware of this rare toxicity as it could be severe, but easily reversible using appropriate surgical treatment. Even if prognosis remains poor for patients with lung cancer, invasive procedures could be considered in this rapidly evolving setting, especially in case of reversible adverse event. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: lung cancer (oncology); unwanted effects / adverse reactions
Mesh:
Substances:
Year: 2018 PMID: 29330272 DOI: 10.1136/bcr-2017-222561
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X